Antibiotic Resistance Market Size, Share, Trends, Growth Outlook

The Global Antibiotic Resistance Market Size is estimated to be US 9.4 Billion in 2024. It is poised to register 6.2% growth over the forecast period from 2024 to 2030 to reach US $ 13.5 billion in 2030.

 

The expanding market is propelled by advancements in diagnostic technologies, particularly the adoption of rapid molecular testing and genotyping. These technologies play a pivotal role in combating antibiotic resistance by enabling swift and precise identification of bacterial strains and their resistance profiles. This capability facilitates the development of targeted and more effective treatment strategies. Companies that specialize in innovative diagnostic tools and technologies are expected to experience heightened demand within the Antibiotic Resistance Market. Leading Companies focusing on Personalized Medicine and Precision Antibiotics, Integration of Artificial Intelligence (AI) and Machine Learning, Global Collaborations and Partnerships, and others to boost market shares in the industry.

 

Antibiotic Resistance Market Overview

The Antibiotic Resistance Market is characterized by the escalating global threat of antibiotic-resistant bacteria, driven by widespread and inappropriate antibiotic use. Market dynamics include robust research and development efforts to discover novel antibiotics and alternative therapies, along with a focus on rapid diagnostics. Regulatory agencies are increasingly emphasizing responsible antibiotic use, offering incentives for drug development. Global initiatives and collaborations aim to address the challenge on an international scale. Despite these efforts, the market faces challenges such as high development costs and economic models that may hinder pharmaceutical investment. The landscape is dynamic, with stakeholders continually adapting strategies to combat the evolving challenges of antibiotic resistance.

 

Antibiotic Resistance Market Dynamics

Market Trends- The rise of antibiotic resistance sends a global alarm, as it could render modern medicine ineffective against infectious diseases.

The surge in antibiotic resistance has become a pressing global issue, causing concern in medical and public health circles. This development poses a substantial threat to the effectiveness of modern medicine in tackling infectious diseases. Once hailed as miraculous, antibiotics are losing their efficacy as bacteria adapt and develop resistance mechanisms. This imperils the treatment of common infections, surgeries, and medical procedures that rely on antibiotics to prevent and control bacterial infections. The diminishing effectiveness of antibiotics raises the stakes, potentially turning routine medical interventions into life-threatening scenarios. Recognizing the gravity of the situation, the World Health Organization (WHO) has identified antibiotic resistance as a paramount threat to global health. Experts caution against a future where commonplace infections could become untreatable, leading to heightened mortality rates and the resurgence of previously controlled diseases. Urgent and collaborative actions on a global scale are imperative to address the underlying causes of antibiotic resistance, advocate for responsible antibiotic usage, and channel investments into research and development for innovative antimicrobial solutions to secure the future of healthcare.

 

Market Driver- Rising Awareness and Initiatives Demand for Antibiotic Resistance Market

The increasing recognition of antibiotic resistance and the launch of diverse initiatives have generated a heightened demand for solutions within the Antibiotic Resistance Market. Governments, healthcare organizations, and international entities are actively advocating for responsible antibiotic usage, conducting awareness campaigns to educate healthcare professionals and the public on the repercussions of antibiotic misuse. This elevated awareness has fostered a need for innovative diagnostics, treatment alternatives, and preventive measures. In response to this demand, pharmaceutical companies and research institutions are investing in the creation of novel antibiotics, alternative therapies, and swift diagnostic tools. The Antibiotic Resistance Market is undergoing a shift toward a more proactive approach to tackling antibiotic resistance, emphasizing collaborative endeavors and the implementation of regulatory measures promoting sustainable antibiotic practices. With increasing awareness, the market is anticipated to witness growing support for research and development initiatives aimed at addressing this crucial global health challenge.

 

Market Opportunity- Scientific efforts focus on finding new treatments to combat bacterial infections beyond traditional antibiotics.

Current scientific endeavors are increasingly focused on discovering innovative treatments for bacterial infections that go beyond traditional antibiotics. Researchers are exploring diverse approaches to tackle the challenges posed by antibiotic resistance, including the development of alternative therapies and novel treatment methods. One avenue of exploration involves the use of bacteriophages—viruses that specifically target and infect bacteria, providing a precise and targeted approach to combating infections. Additionally, there is growing interest in investigating antimicrobial peptides and other naturally occurring compounds from plants and microorganisms as potential alternative antibacterial agents. Moreover, ongoing research is delving into advancements in immunotherapy and the modulation of the host's immune response to enhance the body's natural ability to fight bacterial infections. These varied scientific initiatives aim to surmount the limitations of traditional antibiotics and contribute to a more comprehensive and effective arsenal against bacterial infections.

 

Market Share Analysis- Fluoroquinolones Antibiotic Resistance Market will register the fastest growth

The Global Antibiotic Resistance Market is analyzed across Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, and others. Fluoroquinolones are poised to register the fastest growth. The Fluoroquinolones Antibiotic Resistance Market is characterized by concerns over the growing resistance to fluoroquinolone antibiotics, a broad-spectrum class commonly used to treat bacterial infections. This market involves pharmaceutical companies, research institutions, and healthcare providers, with a focus on addressing and mitigating resistance issues associated with fluoroquinolones. Regulatory bodies are actively involved in monitoring and regulating their use, emphasizing responsible prescribing practices. Ongoing research and development initiatives aim to discover new antibiotics or modify existing ones to enhance efficacy against resistant strains. Global collaborations are vital in addressing the international impact of antibiotic resistance, and clinical practices and prescribing patterns play a significant role in shaping this market.

 

Market Share Analysis- Protein synthesis inhibitors held a significant market share in 2023

The Global Antibiotic Resistance Market is analyzed across various Mechanisms of Action including Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, and others. Of these, Protein synthesis inhibitors held a significant market share in 2023. The Protein Synthesis Inhibitors Antibiotic Resistance Market is characterized by challenges stemming from the emergence of resistance to antibiotics targeting bacterial protein synthesis. This market involves pharmaceutical companies, researchers, and healthcare providers working to develop strategies to combat resistance, including the discovery of novel antibiotics or alternative therapies. Regulatory bodies play an active role in monitoring and regulating the use of protein synthesis inhibitors, aiming to promote responsible prescribing practices. Ongoing research focuses on identifying new compounds or modifying existing ones to enhance efficacy against resistant strains. Global collaborations are essential in addressing the international impact of antibiotic resistance, and clinical practices influence the market by encouraging evidence-based prescribing tailored to local resistance patterns.

 

Antibiotic Resistance Market Segmentation

 By Disease 

• cUTI (Complicated Urinary Tract Infections)
• CDI (Clostridioides difficile Infection)
• ABSSSI (Acute bacterial skin and skin structure infections)
• HABP (Hospital-acquired bacterial pneumonia)
• CABP (Community-acquired pneumonia)
• cIAI (Complicated intra-abdominal infection)
• BSI (Bloodstream infection)

 

By Pathogen

• E. coli
• K. pneumoniae
• P. aeruginosa
• S. aureus
• baumannii
• S. pneumoniae
• H. influenzae
• difficile
• E. faecium

 

By Drug Class

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Combination therapies
• Cephalosporins
• Others

 

By Mechanism of Action

• Protein Synthesis Inhibitors
• Cell Wall Synthesis Inhibitors
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Others

 

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

 Antibiotic Resistance Market Companies

• Melinta Therapeutics
• Basilea Pharmaceutica Ltd.
• Tetraphase Pharmaceuticals
• Theravance Biopharma
• WOCKHARDT
• Paratek Pharmaceuticals, Inc.
• Seres Therapeutics
• ACHAOGEN INC
• Entasis therapeutics
• AbbVie
• Merck and Co Inc

 

*List not exhaustive

Antibiotic Resistance Market Outlook 2023

1 Market Overview

1.1 Introduction to the Antibiotic Resistance Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Antibiotic Resistance Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Antibiotic Resistance Market Companies with Area Served

4.2.2 Products Offerings Global Antibiotic Resistance Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global Antibiotic Resistance Market Trends

6.1 Global Antibiotic Resistance Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Antibiotic Resistance Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Antibiotic Resistance Revenue (USD Million) and CAGR (%) by regions (2018-2030)

 

7 Global Antibiotic Resistance Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Antibiotic Resistance Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Antibiotic Resistance Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Antibiotic Resistance Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Antibiotic Resistance Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Antibiotic Resistance Development Regional Status and Outlook

8.1 Global Antibiotic Resistance Revenue (USD Million) By Regions (2018-2022)

8.2 North America Antibiotic Resistance Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Antibiotic Resistance Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Antibiotic Resistance Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Antibiotic Resistance Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Antibiotic Resistance Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Antibiotic Resistance Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Antibiotic Resistance Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Antibiotic Resistance Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Antibiotic Resistance Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Antibiotic Resistance Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Antibiotic Resistance Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Antibiotic Resistance Revenue (USD Million) by Applications (2018-2022)

8.5 South America Antibiotic Resistance Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Antibiotic Resistance Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Antibiotic Resistance Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Antibiotic Resistance Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Antibiotic Resistance Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Antibiotic Resistance Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Antibiotic Resistance Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Antibiotic Resistance Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Antibiotic Resistance Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Antibiotic Resistance Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Antibiotic Resistance Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Antibiotic Resistance Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Antibiotic Resistance Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Antibiotic Resistance Development Regional Status and Outlook Forecast

11.1 Global Antibiotic Resistance Revenue (USD Million) By Regions (2023-2030)

11.2 North America Antibiotic Resistance Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Antibiotic Resistance Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Antibiotic Resistance Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Antibiotic Resistance Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Antibiotic Resistance Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Antibiotic Resistance Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Antibiotic Resistance Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Antibiotic Resistance Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Antibiotic Resistance Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Antibiotic Resistance Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Antibiotic Resistance Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Antibiotic Resistance Revenue (USD Million), by Applications (2023-2030)

11.5 South America Antibiotic Resistance Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Antibiotic Resistance Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Antibiotic Resistance Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Antibiotic Resistance Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Antibiotic Resistance Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Antibiotic Resistance Revenue (USD Million), by region (2023-2030)

11.6.2 Middle East and Africa Antibiotic Resistance Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Antibiotic Resistance Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Antibiotic Resistance Market Companies with Areas Served

Table 3 Products Offerings Global Antibiotic Resistance Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Antibiotic Resistance Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Antibiotic Resistance Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Antibiotic Resistance Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Table 11 Global Antibiotic Resistance Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Antibiotic Resistance Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Antibiotic Resistance Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Antibiotic Resistance Market Share (%) By Regions (2018-2022)

Table 16 North America Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Table 17 North America Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Table 18 North America Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Table 26 South America Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Table 27 South America Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Table 33 Global Antibiotic Resistance Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Antibiotic Resistance Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Antibiotic Resistance Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Antibiotic Resistance Revenue (USD)By Country (2023-2030)

Table 38 North America Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Table 39 North America Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Antibiotic Resistance Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Antibiotic Resistance Revenue (USD Million) By Country (2023-2030)

Table 47 South America Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Table 48 South America Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Antibiotic Resistance Revenue Market Share (%) By Type (2022)

Figure 5 Global Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Antibiotic Resistance Revenue Market Share (%) By Applications (2022)

Figure 7 Global Antibiotic Resistance Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Antibiotic Resistance Market Share (%) By Regions (2022)

Figure 9 North America Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Antibiotic Resistance Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Antibiotic Resistance Revenue Market Share (%) By Type (2030)

Figure 26 Global Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Antibiotic Resistance Revenue Market Share (%) By Applications (2030)

Figure 28 Global Antibiotic Resistance Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Antibiotic Resistance Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Antibiotic Resistance Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Antibiotic Resistance Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Antibiotic Resistance Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

 

Antibiotic Resistance Market Segmentation

 By Disease 

• cUTI (Complicated Urinary Tract Infections)
• CDI (Clostridioides difficile Infection)
• ABSSSI (Acute bacterial skin and skin structure infections)
• HABP (Hospital-acquired bacterial pneumonia)
• CABP (Community-acquired pneumonia)
• cIAI (Complicated intra-abdominal infection)
• BSI (Bloodstream infection)

 

By Pathogen

• E. coli
• K. pneumoniae
• P. aeruginosa
• S. aureus
• baumannii
• S. pneumoniae
• H. influenzae
• difficile
• E. faecium

 

By Drug Class

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Combination therapies
• Cephalosporins
• Others

 

By Mechanism of Action

• Protein Synthesis Inhibitors
• Cell Wall Synthesis Inhibitors
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Others

 

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)